e-Casos clínicos
Respuesta a ingenol mebutato en los pacientes con queratosis actínicas en la práctica clínica
Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses
A. Batalla
, Á. Flórez, C. Feal, G. Peón, M.T. Abalde, L. Salgado-Boquete, C. de la Torre
Autor para correspondencia
Servicio de Dermatología, Centro de Especialidades de Mollabao, Xestión Integrada Pontevedra-Salnés, Pontevedra, España
Leído
9619
Vecesse ha leído el artículo
2433
Total PDF
7186
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 33 | 5 | 38 |
| 2025 5 | 166 | 30 | 196 |
| 2025 4 | 150 | 23 | 173 |
| 2025 3 | 163 | 22 | 185 |
| 2025 2 | 149 | 28 | 177 |
| 2025 1 | 110 | 26 | 136 |
| 2024 12 | 110 | 33 | 143 |
| 2024 11 | 106 | 72 | 178 |
| 2024 10 | 77 | 35 | 112 |
| 2024 9 | 132 | 28 | 160 |
| 2024 8 | 151 | 50 | 201 |
| 2024 7 | 91 | 36 | 127 |
| 2024 6 | 116 | 42 | 158 |
| 2024 5 | 97 | 47 | 144 |
| 2024 4 | 102 | 34 | 136 |
| 2024 3 | 107 | 30 | 137 |
| 2024 2 | 82 | 28 | 110 |
| 2024 1 | 96 | 28 | 124 |
| 2023 12 | 104 | 19 | 123 |
| 2023 11 | 128 | 28 | 156 |
| 2023 10 | 100 | 17 | 117 |
| 2023 9 | 109 | 19 | 128 |
| 2023 8 | 121 | 16 | 137 |
| 2023 7 | 169 | 31 | 200 |
| 2023 6 | 105 | 17 | 122 |
| 2023 5 | 166 | 24 | 190 |
| 2023 4 | 104 | 20 | 124 |
| 2023 3 | 131 | 22 | 153 |
| 2023 2 | 152 | 25 | 177 |
| 2022 1 | 106 | 29 | 135 |
| 2022 12 | 96 | 36 | 132 |
| 2022 11 | 117 | 55 | 172 |
| 2022 10 | 96 | 53 | 149 |
| 2022 9 | 105 | 63 | 168 |
| 2022 8 | 112 | 50 | 162 |
| 2022 7 | 103 | 62 | 165 |
| 2022 6 | 109 | 39 | 148 |
| 2022 5 | 114 | 44 | 158 |
| 2022 4 | 96 | 34 | 130 |
| 2022 3 | 98 | 63 | 161 |
| 2022 2 | 94 | 38 | 132 |
| 2021 1 | 108 | 39 | 147 |
| 2021 12 | 77 | 70 | 147 |
| 2021 11 | 96 | 38 | 134 |
| 2021 10 | 98 | 60 | 158 |
| 2021 9 | 74 | 36 | 110 |
| 2021 8 | 109 | 27 | 136 |
| 2021 7 | 86 | 33 | 119 |
| 2021 6 | 104 | 36 | 140 |
| 2021 5 | 83 | 23 | 106 |
| 2021 4 | 204 | 71 | 275 |
| 2021 3 | 129 | 27 | 156 |
| 2021 2 | 71 | 27 | 98 |
| 2020 1 | 83 | 23 | 106 |
| 2020 12 | 70 | 18 | 88 |
| 2020 11 | 81 | 27 | 108 |
| 2020 10 | 79 | 23 | 102 |
| 2020 9 | 79 | 19 | 98 |
| 2020 8 | 101 | 21 | 122 |
| 2020 7 | 94 | 14 | 108 |
| 2020 6 | 95 | 38 | 133 |
| 2020 5 | 82 | 33 | 115 |
| 2020 4 | 83 | 31 | 114 |
| 2020 3 | 90 | 15 | 105 |
| 2020 2 | 13 | 12 | 25 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 2 | 2 | 4 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 1 | 3 | 4 |
| 2019 9 | 4 | 1 | 5 |
| 2019 8 | 0 | 7 | 7 |
| 2019 7 | 0 | 7 | 7 |
| 2019 6 | 2 | 21 | 23 |
| 2019 5 | 0 | 29 | 29 |
| 2019 4 | 2 | 11 | 13 |
| 2019 3 | 2 | 6 | 8 |
| 2019 2 | 0 | 4 | 4 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 3 | 4 | 7 |
| 2018 11 | 1 | 7 | 8 |
| 2018 10 | 4 | 4 | 8 |
| 2018 9 | 4 | 0 | 4 |
| 2018 7 | 1 | 0 | 1 |
| 2018 6 | 1 | 1 | 2 |
| 2018 5 | 0 | 5 | 5 |
| 2018 4 | 0 | 8 | 8 |
| 2018 3 | 1 | 5 | 6 |
| 2018 2 | 57 | 15 | 72 |
| 2018 1 | 54 | 22 | 76 |
| 2017 12 | 49 | 28 | 77 |
| 2017 11 | 7 | 1 | 8 |
| 2017 10 | 3 | 6 | 9 |
| 2017 9 | 6 | 3 | 9 |
| 2017 8 | 5 | 1 | 6 |
| 2017 7 | 3 | 2 | 5 |
| 2017 6 | 12 | 1 | 13 |
| 2017 5 | 7 | 0 | 7 |
| 2017 4 | 9 | 0 | 9 |
| 2017 3 | 9 | 1 | 10 |
| 2017 2 | 8 | 1 | 9 |
| 2016 1 | 8 | 1 | 9 |
| 2016 12 | 24 | 4 | 28 |
| 2016 11 | 17 | 5 | 22 |
| 2016 10 | 6 | 6 | 12 |
| 2016 9 | 0 | 13 | 13 |
| 2016 8 | 3 | 7 | 10 |
| 2016 7 | 3 | 5 | 8 |
| 2016 6 | 4 | 5 | 9 |
| 2016 5 | 0 | 2 | 2 |
| 2015 12 | 0 | 11 | 11 |
Mostrar todo
